All Search Results

Displaying Results "synthetic biology"

News Releases

Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence

environmental evaluation, with applications spanning cognitive and physiological monitoring, flexible electronics, additive smart materials, and synthetic biology. AeroVironment continues to expand its defense technology portfolio beyond its established Switchblade loitering munition and Puma unmanned

More news about: USA News Group


Feb 18, 2026, 08:23 ET BiomEdit Initiates Final Field Safety Trial for Non-Antibiotic Poultry Biologic, Advancing Toward USDA Conditional Licensure

performance."About BiomEditBiomEdit is an animal health biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors including Anterra

More news about: BiomEdit


Feb 18, 2026, 08:00 ET Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Feb 12, 2026, 17:52 ET UTulsa's Hurricane Ventures announces investment in BioReact

shorten development cycles. The platform requires no coding expertise and has applications across industries like biopharma, industrial biotech and synthetic biology."The support from The University of Tulsa and Hurricane Ventures allows us to accelerate development of software that genuinely serves

More news about: The University of Tulsa


Feb 10, 2026, 09:04 ET Simplicis Named Launch Partner For The Beckman Coulter Life Sciences Echo Ready Digital Solutions Program

contactless liquid dispensing and supports key workflows in early drug discovery as well as emerging applications in biotherapeutics engineering, synthetic biology, and nanotechnology. The technology supports highly combinatorial workflows, miniaturization, and enables the production of high-quality assay-ready

More news about: Simplicis